Search - tctmd.com

Displaying 101 - 120 of 296

Sort: Relevancy | Date

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Advertisement

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

December 2022 News Roundup

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

November 2022 News Roundup

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

July 2022 News Roundup

Registry Data Hint at MACE Benefit With Renal Denervation

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Good News and Bad for High-Intensity Statin Use in ASCVD

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

More Evidence Links Breast Arterial Calcification and CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content